| 000 | 01549 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513130556.0 | ||
| 264 | 0 | _c19971120 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a1079-5642 | ||
| 024 | 7 |
_a10.1161/01.atv.17.10.2066 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, S R | |
| 245 | 0 | 0 |
_aModified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease. _h[electronic resource] |
| 260 |
_bArteriosclerosis, thrombosis, and vascular biology _cOct 1997 |
||
| 300 |
_a2066-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlprostadil _xmetabolism |
| 650 | 0 | 4 |
_aCyclic AMP _xbiosynthesis |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 |
_aEpoprostenol _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonocytes _xmetabolism |
| 650 | 0 | 4 | _aPeripheral Vascular Diseases |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aYang, Q | |
| 700 | 1 | _aKoller, E | |
| 700 | 1 | _aKurtaran, A | |
| 700 | 1 | _aBischof, C | |
| 700 | 1 | _aLeimer, M | |
| 700 | 1 | _aRauscha, F | |
| 700 | 1 | _aPidlich, J | |
| 700 | 1 | _aVirgolini, I | |
| 773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 17 _gno. 10 _gp. 2066-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.atv.17.10.2066 _zAvailable from publisher's website |
| 999 |
_c9321797 _d9321797 |
||